Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Adachi

Showing results (1-10 of 317) with videos related to

Pageof 32
Sort By:
Best Practice & Research. Clinical Rheumatology|November 23, 2005
In whom and how to prevent glucocorticoid-induced osteoporosisJonathan D Adachi, Alexandra Papaioannou
Clinical Interventions in Aging|November 30, 2007
Review of the safety and efficacy of risedronate for the treatment of male osteoporosisRaja Bobba, Jonathan D Adachi
Drug Safety|July 29, 2005
Benefit-risk assessment of raloxifene in postmenopausal osteoporosisAnn Cranney, Jonathan D Adachi
The Journal of Steroid Biochemistry and Molecular Biology|May 18, 2004
The treatment of glucocorticoid-induced osteoporosisDana Cohen, Jonathan D Adachi
Current Osteoporosis Reports|January 7, 2021
Therapies for Preventing Bone Loss with Glucocorticoid TreatmentArnav Agarwal, Jonathan D Adachi
Treatments in Endocrinology|April 19, 2005
Corticosteroid-induced osteoporosis: a guide to optimum managementAnn Cranney, Jonathan D Adachi
The Journal of Rheumatology|October 3, 2014
Systemic lupus erythematosus, osteoporosis, and fracturesJonathan D Adachi, Arthur Lau
Expert Review of Endocrinology & Metabolism|May 17, 2019
Glucocorticoid induced osteoporosisKira Hu, Jonathan D Adachi
The Journal of Rheumatology|August 13, 2009
Resolution of osteonecrosis of the jaw after teriparatide [recombinant human PTH-(1-34)] therapyArthur N Lau, Jonathan D Adachi
Therapeutics and Clinical Risk Management|November 11, 2010
Role of teriparatide in treatment of glucocorticoid-induced osteoporosisArthur N Lau, Jonathan D Adachi
Pageof 32

Showing results (1-10 of 317) with videos related to

Sort By:
Pageof 32
Best Practice & Research. Clinical Rheumatology|November 23, 2005
In whom and how to prevent glucocorticoid-induced osteoporosisJonathan D Adachi, Alexandra Papaioannou
Clinical Interventions in Aging|November 30, 2007
Review of the safety and efficacy of risedronate for the treatment of male osteoporosisRaja Bobba, Jonathan D Adachi
Drug Safety|July 29, 2005
Benefit-risk assessment of raloxifene in postmenopausal osteoporosisAnn Cranney, Jonathan D Adachi
The Journal of Steroid Biochemistry and Molecular Biology|May 18, 2004
The treatment of glucocorticoid-induced osteoporosisDana Cohen, Jonathan D Adachi
Current Osteoporosis Reports|January 7, 2021
Therapies for Preventing Bone Loss with Glucocorticoid TreatmentArnav Agarwal, Jonathan D Adachi
Treatments in Endocrinology|April 19, 2005
Corticosteroid-induced osteoporosis: a guide to optimum managementAnn Cranney, Jonathan D Adachi
The Journal of Rheumatology|October 3, 2014
Systemic lupus erythematosus, osteoporosis, and fracturesJonathan D Adachi, Arthur Lau
Expert Review of Endocrinology & Metabolism|May 17, 2019
Glucocorticoid induced osteoporosisKira Hu, Jonathan D Adachi
The Journal of Rheumatology|August 13, 2009
Resolution of osteonecrosis of the jaw after teriparatide [recombinant human PTH-(1-34)] therapyArthur N Lau, Jonathan D Adachi
Therapeutics and Clinical Risk Management|November 11, 2010
Role of teriparatide in treatment of glucocorticoid-induced osteoporosisArthur N Lau, Jonathan D Adachi
Pageof 32